Aridis Pharmaceuticals, Inc. - ARDS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2023 · Q1 2023
Value (USD)
Total reported value ($000)
$259K
QoQ value delta ($000)
-$201K (-43.7%)
Implied price effect (QoQ)
-29.72%
Shares
Total shares
1,196,034
QoQ shares delta
-296,903 (-19.89%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ARDS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2023)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
COMMONWEALTH EQUITY SERVICES, LLC 142 646,000 0.0%
STATE STREET CORP 44 202,247 0.0%
GEODE CAPITAL MANAGEMENT, LLC 31 143,034 0.0%
VANGUARD GROUP INC 29 136,197 0.0%
NORTHERN TRUST CORP 6 28,104 0.0%
CITADEL ADVISORS LLC 4 19,000 0.0%
Tower Research Capital LLC (TRC) 3 16,363 0.0%
WELLS FARGO & COMPANY/MN 0 1,459 0.0%
GROUP ONE TRADING, L.P. 0 2,337 0.0%
SIMPLEX TRADING, LLC 0 1,293 0.0%